Evidence map›Paper›PMID 30522766›Full record

ArticleKidney international2019

Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis.

Vivek Kasinath, Osman A Yilmam, Mayuko Uehara, Liwei Jiang, Farideh Ordikhani, Xiaofei Li, David J Salant, Reza Abdi

Open access · bronzeAbstract read
In one paragraph

Article in Kidney international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. The lymphatics in kidney health and disease.Nature reviews. Nephrology · 2021
    Review
  16. Review
  17. Review
  18. Emerging roles for lymphatics in acute kidney injury: Beneficial or maleficent?Experimental biology and medicine (Maywood, N.J.) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vivek KasinathTransplantation Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Osman A YilmamTransplantation Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Mayuko UeharaTransplantation Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Liwei JiangTransplantation Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Farideh OrdikhaniTransplantation Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Xiaofei LiTransplantation Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
David J SalantRenal Section, Boston University Medical Center, Boston, Massachusetts, USA.
Reza AbdiTransplantation Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: rabdi@rics.bwh.harvard.edu.
Brigham and Women's Hospital · USBoston University · US

Funding

TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007527 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1986 to 2021
$8.8M
A novel approach to delivering therapeutics in heart transplantationR01HL145813 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2019 to 2022
$2.6M
Protection of organ transplant from ischemia reperfusion injuriesR01AI126596 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2016 to 2020
$2.6M
Ischemia-reperfusion injury in transplantation: novel cytoprotection strategiesR01AI091930 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2011 to 2015
$2.1M
PI3K-gamma regulates T cell mediated alloimmunityR01HL141815 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2018 to 2021
$1.6M
NHLBI NIH HHS R01 HL141815NHLBI NIH HHS R01 HL145813NIAID NIH HHS R01 AI091930NIAID NIH HHS R01 AI126596NIDDK NIH HHS T32 DK007527
6 · The paper itself

Abstract

Crescentic glomerulonephritis is an inflammatory condition characterized by rapid deterioration of kidney function. Previous studies of crescentic glomerulonephritis have focused on immune activation in the kidney. However, the role of fibroblastic reticular cells, which reside in the stromal compartment of the kidney lymph node, has not been studied in this condition. We investigated the activation of kidney lymph node-resident fibroblastic reticular cells in nephrotoxic serum nephritis, a classic murine model of crescentic glomerulonephritis. We found that increased deposition of extracellular matrix fibers by fibroblastic reticular cells in the kidney lymph node was associated with the propagation of high endothelial venules, specialized blood vessels through which lymphocytes enter the lymph node, as well as with expansion of the lymphatic vasculature. The kidney lymph node also contained an expanding population of pro-inflammatory T cells. Removal of the kidney lymph node, depletion of fibroblastic reticular cells, and treatment with anti-podoplanin antibody each resulted in reduction of kidney injury. Our findings suggest that modulating the activity of fibroblastic reticular cells may be a novel therapeutic approach in crescentic glomerulonephritis.

Indexed as

AnimalsCapillariesDisease Models, AnimalExtracellular MatrixFibroblastsGlomerulonephritisHumansKidneyLymphatic VesselsLymph NodesMaleMiceMice, Inbred C57BLT-Lymphocytesacute kidney injuryanti–glomerular basement membrane diseaseglomerulonephritisGoodpasture syndromelymphocyte

Identifiers

PMID30522766
PMCPMC6342621
OpenAlexW2902732744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.